Pharmacological and non-pharmacological treatments for refractory paediatric Still's disease: a scoping review. [PDF]
Twynam-Perkins E, Martin N, McLellan K.
europepmc +1 more source
Pediatric rheumatic diseases and vaccinations: a promising alliance. [PDF]
Corsello G +4 more
europepmc +1 more source
Long-Term Safety of Anti-Interleukin-1 Medications in Children with Rheumatic Diseases: a Systematic Review. [PDF]
Isa M, Tiller GM, Liew DFL, Renton WD.
europepmc +1 more source
Targeted Anti-Inflammatory Therapy in Cardiovascular Events: Challenges and Opportunities. [PDF]
Ma T, Wang L, Yan X, Li F.
europepmc +1 more source
Anti-JNK2 peptide–siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice [PDF]
Akk, Antonina +11 more
core +1 more source
Comparative effectiveness and safety of systemic therapies for treatment-naïve, PD-L1 expression <1% advanced NSCLC: a systematic review and network meta-analysis. [PDF]
Zhou M +10 more
europepmc +1 more source
Optimal Medical Therapy Targeting Lipids and Inflammation for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention. [PDF]
Forzano I +17 more
europepmc +1 more source
Sensorineural hearing loss in anti-interleukin-1 treated CAPS patients: risk factors and real-life barriers-an observational study. [PDF]
Satirer Ö +5 more
europepmc +1 more source
The British Society For Rheumatology guideline for the management of gout [PDF]
Cameron, Stewart +13 more
core +2 more sources
Tribulations of Randomized Controlled Trials: Testing the Inflammatory Hypothesis of Heart Failure. [PDF]
Buckley LF, Weber BN.
europepmc +1 more source

